SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Rosenquist Richard)
 

Sökning: WFRF:(Rosenquist Richard) > (2020-2024) > Implementation of W...

  • Cuppen, EdwinHartwig Medical Foundation, Amsterdam, the Netherlands;Center for Molecular Medicine and Oncode Institute, University Medical Center, Utrecht, the Netherlands (författare)

Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care

  • Artikel/kapitelEngelska2022

Förlag, utgivningsår, omfång ...

  • American Society of Clinical Oncology,2022
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-193342
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-193342URI
  • https://doi.org/10.1200/po.22.00245DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding agencies: Hartwig Medical Foundation (Hans van Snellenberg, Edwin Cuppen)receives funding from Hartwig Foundation, the Dutch Cancer Foundation(KWF), ZonMW and Illumina Inc. R.R. received funding from the SwedishCancer Society, the Swedish Research Council, the Knut and AliceWallenberg Foundation, Karolinska Institutet, Karolinska UniversityHospital, and Radiumhemmets Forskningsfonder, Stockholm. Universityof Twente, Enschede, The Netherlands (M.I.) receives funding fromIllumina Inc. C.G.M. is supported by NCI CA 197695. S.F. receivedsupport from the National Center for Tumor Diseases and the German Cancer Consortium. C.C. is supported by funding from CRUK (grantnumbers A17197, A27657 and A29580) and a European ResearchCouncil Advanced Award (grant number 694620). T.J.P. holds theCanada Research Chair in Translational Genomics and is supported by aSenior Investigator Award from the Ontario Institute for Cancer Researchand the Gattuso-Slaight Personalized Cancer Medicine Fund.
  • PURPOSE The combination of whole-genome and transcriptome sequencing (WGTS) is expected to transformdiagnosis and treatment for patients with cancer. WGTS is a comprehensive precision diagnostic test that isstarting to replace the standard of care for oncology molecular testing in health care systems around the world;however, the implementation and widescale adoption of this best-in-class testing is lacking.METHODS Here, we address the barriers in integrating WGTS for cancer diagnostics and treatment selection andanswer questions regarding utility in different cancer types, cost-effectiveness and affordability, and otherpractical considerations for WGTS implementation.RESULTS We review the current studies implementing WGTS in health care systems and provide a synopsis of theclinical evidence and insights into practical considerations for WGTS implementation. We reflect on regulatory,costs, reimbursement, and incidental findings aspects of this test.CONCLUSION WGTS is an appropriate comprehensive clinical test for many tumor types and can replacemultiple, cascade testing approaches currently performed. Decreasing sequencing cost, increasing number ofclinically relevant aberrations and discovery of more complex biomarkers of treatment response, should pave theway for health care systems and laboratories in implementing WGTS into clinical practice, to transform diagnosisand treatment for patients with cancer.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Elemento, OlivierCaryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA (författare)
  • Rosenquist, RichardDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden;Clinical Genetics, Karolinska University Hospital, Solna, Sweden (författare)
  • Nikic, SvetlanaIllumina Productos de España, S.L.U., Plaza Pablo Ruiz Picasso, Madrid, Spain (författare)
  • IJzerman, MaartenErasmus School of Health Policy & Management, Erasmus University, Rotterdam, the Netherlands;Centre for Cancer Research, University of Melbourne, Melbourne, Australia (författare)
  • Zaleski, Isabelle DurandUniversité de Paris, CRESS, INSERM, INRA, URCEco, AP-HP, Hôpital de l'Hôtel Dieu, Paris, France (författare)
  • Frederix, GeertJulius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands (författare)
  • Levin, Lars-Åke,Professor,1960-Linköpings universitet,Avdelningen för samhälle och hälsa,Medicinska fakulteten(Swepub:liu)larle77 (författare)
  • Mullighan, Charles G.Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA (författare)
  • Buettner, ReinhardInstitute of Pathology, University Hospital Cologne, Germany (författare)
  • Pugh, Trevor J.Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada;Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada;Ontario Institute for Cancer Research, Toronto, Ontario, Canada (författare)
  • Grimmond, SeanCentre for Cancer Research, University of Melbourne, Melbourne, Australia (författare)
  • Caldas, CarlosCancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge, Cambridge, United Kingdom (författare)
  • Andre, FabriceInstitut Gustave Roussy, Villejuif, France (författare)
  • Custers, IlseStichting Lygature, Utrecht, the Netherlands (författare)
  • Campo, EliasInstitut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain;Centro de Investigación Biomédica en Red, Cáncer (CIBERONC), Madrid, Spain;Hematopathology Unit, Hospital Clínic of Barcelona, Barcelona, Spain;University of Barcelona, Barcelona, Spain (författare)
  • van Snellenberg, HansHartwig Medical Foundation, Amsterdam, the Netherlands (författare)
  • Schuh, AnnaUniversity of Oxford, Oxford, United Kingdom (författare)
  • Nakagawa, HidewakiLaboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan (författare)
  • von Kalle, ChristofBerlin Institute of Health at Charité—Universitätsmedizin Berlin, Clinical Study Center, Berlin, Germany (författare)
  • Haferlach, TorstenMunich Leukemia Laboratory, Munich, Germany (författare)
  • Fröhling, StefanDivision of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany;German Cancer Consortium (DKTK), Heidelberg, Germany (författare)
  • Jobanputra, VaidehiNew York Genome Center; Department of Pathology, Columbia University Irving Medical Center, New York, NY (författare)
  • Hartwig Medical Foundation, Amsterdam, the Netherlands;Center for Molecular Medicine and Oncode Institute, University Medical Center, Utrecht, the NetherlandsCaryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:JCO Precision Oncology: American Society of Clinical Oncology62473-4284

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy